GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
Clinical trial NCT01245062 · COMPLETED
Trial details
- NCT number
- NCT01245062
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-22
- Primary completion
- 2011-10-26
- Enrollment
- 322
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.